About Us
Dynaccurate emerged from a group of health informatics experts working on technology that began in a series of campus research projects. Dr Silvio Cardoso, CTO, was focussing on how to develop interoperability tools for clinical data, and subsequently partnered with with Dermot Doyle, CEO, to commercialise the technology. The team won funding from the Luxembourg National Research Fund (FNR) in 2020 and then successfully applied to, and graduated from, the national startup support programme called Fit4STart, run by Luxinnovation in 2022.
The company has contributed to standards discussions in both Luxembourg, where Dermot was Chair/Co-Chair of the Gaia-X Luxembourg Working Groups on Trusted AI and Standards & Interoperability, and also in the UK, where the company made a presentation at the NHS England sponsored INTEROPen Hackathon on medicines interoperability.
Since then, and after hundreds of conversations with doctors, nurses, pharmacists, interoperability experts, data scientists and other experts in the health, pharma and life science sectors, we realised that we had to provide end-to-end clinical applications. Doctors and nurses are simply too busy focusing on patient treatment and wellness to think about individual innovations in data science and AI. At the same time, they need as much support as modern technology can give to them. For this reason, we decided to compact all of our technology expertise in AI, interoperability and blockchain into a single clinical application layer.
Our vision is a world where patient data is accurate, easily managed, and accessible to the clinician, patient and researcher from the same source.
Providing pharmacogenomic (PGx) services since 2017, Pillcheck helps individuals and their healthcare providers choose the right medications to feel better sooner. Many health plans partner with Pillcheck to bring the positive health impacts of precision medicine to their members.
Pillcheck was the first platform combining DNA analysis with clinical pharmacy services, and we remain leaders in the field. We operate in North America and Europe, complying with healthcare and data privacy regulations globally.
Our multi-lingual software-enabled service integrates expert pharmacist reviews and delivers the consistent application of precision medicine insights for individuals, businesses, and healthcare providers. Pillcheck’s technology architecture addresses the demand for rapid deployment, flexible configuration, and evolving precision medicine programs over time based on data analysis.
BUILDING BRIDGES FOR THE FUTURE OF THE INTERNET
NGI Sargasso is a European Commission-funded cascade funding program dedicated to fostering innovation and strengthening collaboration between the European Union, the United States, and Canada in the field of next-generation internet (NGI) technologies.
Our mission is to accelerate the development of human-centric and trustworthy internet solutions that embody openness, inclusivity, and sustainability.
We go beyond funding by offering beneficiaries a complete training program to equip them with the tools to succeed in business development and market research.